Quantitative imaging of tumour blood flow by contrast-enhanced magnetic resonance imaging by Pahernik, S et al.
Tumour blood flow as a result of angiogenesis plays a key role in
growth, formation of metastasis, as well as detection and treatment
of malignant solid tumours (Folkman, 1995). Quantitative analysis
of tumour blood flow is of paramount importance for the assess-
ment of microvascular function, for the successful delivery of
therapeutic agents, for improving diagnostic procedures and
current treatment options, and for the development of novel anti-
vascular treatment strategies (Jain, 1998). Knowledge about
tumour vascular pathophysiology is highly relevant for the prog-
nosis of cancer patients (Weidner et al, 1991; Hoeckel et al, 1996)
and can be used to plan and to select optimal treatment regimes for
patients, thus individualizing cancer therapy. 
Sensitivity of solid tumours to various treatment modalities is
critically determined by tumour blood flow. Blood flow deter-
mines microenvironmental parameters such as tissue oxygenation,
pH distribution, bioenergetic status and the nutrient supply which
influence sensitivity of malignant cells to anticancer treatment
procedures (Vaupel et al, 1989). Cells outgrowing their nutrient
supply induce hypoxic regions within the tumour with quiescent
and necrotic cells. Hypoxic cells are more resistant to most treat-
ment modalities due to their altered physiologic and metabolic
state. With respect to radiotherapy, treatment is greatly dependent
upon oxygen supply to the tumour which is governed by the blood
flow. In chemo- and immunotherapy, sufficient vascular supply
and blood flow is necessary for the delivery of cytotoxic agents or
cells to the tumour. In the case of hyperthermia, tumour blood flow
is the main route for heat transfer leading to a reduced efficacy in
highly perfused areas of the tumour. 
A noninvasive in vivo approach enabling quantitative imaging
of tumour blood flow is highly desirable and clinically powerful,
in particular if the method would encompass the entire tumour and
could be repeated frequently. Magnetic resonance imaging (MRI)
is a versatile technique which offers the potential to fulfil these
requirements (Henderson et al, 2000). Recent technical improve-
ments concerning ultrafast MRI protocols such as echo planar
imaging or snapshot FLASH which allow more rapid acquisition
times and/or higher spatial resolution widen the potential for func-
tional applications. Several studies have shown that differences in
tumour vasculature are associated with different patterns of
contrast enhancement (Mayr et al, 1996; Degani et al, 1997;
Hawighorst et al, 1998). However, an understanding of local
tumour pathophysiology, and thus, of signal enhancement patterns
in MRI after the administration of paramagnetic contrast agents, is
required in order to attribute parameters obtained by MRI to
morphology and function of tumour vasculature. Recently, a ultra-
fast MRI technique, that is T1 mapping ensuring linearity between
tracer concentration and MR signal, has been introduced to obtain
concentration time data from MR images (Deichmann and Haase,
1992). This technique was used to assess microcirculatory changes
via a perfusion index in patients with rectal carcinoma during
chemoirradiation (de Vries et al, 2000). Moreover, the authors
could demonstrate that this perfusion index, as measured before
onset of treatment, is predictive for therapy outcome (de Vries et al,
2001). However, the perfusion index is influenced not only by
tumour perfusion, but also by capillary permeability-surface product.
In order to improve characterization of tumour microcirculation
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cation of tumour blood flow. 
The aim of the present study was to validate a promising
approach combining the ultrafast T1 mapping technique (de Vries
et al, 2000) with a more complex tracer kinetic model (Griebel
et al, 1997) which takes into account the specific pharmacokinetic
properties of the widely used contrast agent gadopentetate dimeg-
lumine (Gd-DTPA). The approach has been validated in vivo by
correlating the results with data obtained from iodoantipyrine
autoradiography as the reference method for the measurement of
tumour blood flow at high spatial resolution. 
MATERIAL AND METHODS 
Dynamic MR imaging 
MRI measurements were performed on a 400 MHz magnetic
resonance system with 9.4 T (DMX 400, Bruker, Karlsruhe,
Germany). For calculation of T1 maps, an inversion recovery snap-
shot FLASH pulse sequence was implemented into the MR system
(Nekolla et al, 1992). After one initial non-selective fast passage
adiabatic inversion pulse, 20 rapid T1-weighted snapshot FLASH
images were acquired within 2.5 s. To guarantee a sufficiently
accurate sampling of fast relaxation dynamics in contrast-
enhanced tissue and blood, a short repetition time and gradient
echo time (TR = 2.3 ms, TE = 1.1 ms, flip angle = 5˚) was used.
Data were acquired with a matrix size of 64 × 128 and zero filled
to a 128 × 128 matrix. A field of view of 25–30 mm provided an
in-plane resolution of 250 × 250 µ m2. The slice thickness was 750
µ m. After bolus administration of a paramagnetic contrast agent,
very short T1 relaxation times occur in tissue, and especially in
arterial blood. The accurate evaluation of short T1 relaxation times
depends essentially on the fast acquisition of the early relaxation
dynamics. Since the image signal intensity of a snapshot FLASH
image mostly represents the longitudinal magnetization, which is
present at the beginning of the acquisition of the zero-phase
encoding line, a phase-encoding scheme sampling the low
frequency part of raw matrix at the beginning of each sequence
improves the measurement of small T1 values as compared to
conventional sequential phase encoding. Therefore, our measure-
ments employed an asymmetrical sequential phase-encoding
scheme, where the initial 16 (high frequency) rows of raw data
matrix are cut off and appended at the end of k-space sampling. 
From the acquired T1-weighted Snapshot FLASH images, T1
maps are calculated using a 3-parameter least squares fit on a
pixel-by-pixel basis taking into account both T1 relaxation and
progressive saturation effects (Nekolla et al, 1992). To ensure that
B1 inhomogeneities do not degrade the accuracy of the T1
estimates a low flip angle approximation was used (Deichmann
and Haase, 1992). This approximation provides stable T1 estimates
for flip angles between 2˚ to 8˚. This methodological approach
ensures linearity between concentration of the contrast agent and
T1 relaxation rate (Donahue et al, 1994). This approach has been
recommended for dynamic MR studies whenever it is planned to
perform a quantitative analysis by tracer kinetic modelling
(Diesbourg et al, 1992; Tong et al, 1993; Donahue et al, 1994). 
Concentration time data 
The contrast agent gadopentetate dimeglumine (Gd-DTPA,
Magnevist™, Schering AG, Berlin, Germany) was used in this
study. Gadopentetate dimeglumine is a low molecular-weight
tracer (MW 548 d) with extracellular distribution and renal excre-
tion which behaves in tumours as intermediate between a freely
diffusible and an intravascular tracer. 
For the dynamic studies, 4 transaxial precontrast T1 maps,
which were positioned to intersect both heart and tumour, were
acquired. Next, 0.05 mmol kg–1 body weight gadopentetate dimeg-
lumine was infused at 0.125 ml min–1 for 4 min. A total of 47 T1
maps were acquired within 60 min after onset of contrast agent
infusion. To guarantee accurate T1 maps during continuous se-
quence repetition a full recovery of the longitudinal magnetization
between the application of subsequent inversion pulses is neces-
sary. Therefore, temporal resolution of T1 mapping is limited to
10s during the initial sampling period of 2 min, which ensures full
recovery of T1 magnetization. As a consequence, a prolonged
bolus of 4 min infusion time of Gd-DTPA was used to sample
sufficient data points for the precise assessment of the up-slope
part of concentration–time curves in arterial blood and tissue. 
To measure the arterial input function, regions of interest (ROIs)
were defined in the centre of the cavum of the left ventricle. To
exclude motion-derived artifacts during measurements of gadopen-
tetate dimeglumine concentration within the left ventricle, only
time courses from pixels with a steep initial slope of T1 relaxation
rate data (above the 75% quartile) were included for calculation of
the arterial input function (Rempp et al, 1994). A flow compensa-
tion was not necessary. The evaluation of the arterial input func-
tion by using inversion recovery snapshot FLASH sequences has
been validated previously by an independent study applying
sequential arterial and venous blood sampling during MRI (Fritz-
Hansen et al, 1996). 
Concentration time curves, C(t), for arterial blood and tumour
tissue were calculated from changes in T1 relaxation rates [∆ R(t)]
between the pre-and postcontrast images according to the following
formula:
whereas T1pre and T1post(t) denote the T1 relaxation time before and
after the onset of gadopentetate dimeglumine injection, respec-
tively, and β denotes the relaxivity of the contrast agent. It was
assumed that β is identical for blood and tissue which has previ-
ously been shown experimentally (Donahue et al, 1994). 
The basic assumption of Eq. (1) is the linearity between T1
relaxation rate and the gadopentetate dimeglumine concentration.
To verify this assumption and to estimate a reliable in vivo value
for the relaxivity, β , an additional study using the same experi-
mental model was performed. Hereby, gadopentetate dimeg-
lumine, at doses of 0.05, 0.1, 0.15 and 0.3 mmol kg–1 body
weight, was infused via the superior vena cava for 4 min at an
infusion rate of 0.125 ml min–1. 30 min afterwards, T1 maps were
acquired with the aforementioned methodology, and blood
samples were taken simultaneously from the carotid artery via a
polyethylene catheter (Portex Ltd, Hythe, Kent, England) which
was inserted before onset of the MR experiments. Immediately
afterwards, blood was centrifuged, and T1 relaxation rate was
measured ex vivo in the diluted plasma aliquots. Next, the plasma
was frozen until analysis of the concentration of gadopentetate
dimeglumine by means of inductive coupled plasma atomic
spectroscopy. 
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T1 perTracer kinetic model for quantification of tumour
blood flow 
For the quantification of tumour blood flow we applied a novel
tracer kinetic model (Griebel et al, 1997). The model is an exten-
sion of an approach originally developed by Meier and Zierler
(1963). Although the approach of Meier and Zierler was designed
originally for intravascular tracers, their assumptions are not
restricted to this use. It is in particular suitable for extracellular
contrast agents, and for an arbitrarily shaped bolus at the arterial
entry into the tissue, and is consequently not restricted to first pass
studies. The basic assumptions for the tracer kinetic model are: (a)
stationarity of flow distribution with respect to the observed time
scale; (b) representativity of the tracer for total fluid; and (c) inert-
ness of the tracer showing no interactions with tissue and proteins. 
The concentration–time data were fitted to following mathemat-
ical expression using a nonlinear algorithm: 
where Ct(t) and Ca(t) represent concentration–time curves in
tumour tissue and arterial blood, respectively, pt denotes tissue
perfusion of the tumour and h(t) transit time distribution, which is
the distribution of transit times of tracer molecules through the
tissue after an instantaneous bolus. 
For an extracellular tracer such as gadopentetate dimeglumine,
the capillary permeability is so low that only a fraction α of
the tracer enters the interstitial space, while the remaining fraction
(1-α ), behaves exactly like an intravascular tracer. In line with
Zierler (1963), the frequency function h(t) for extracellular tracers
such as gadopentetate dimeglumine can be split into two parts: the
fraction α of tracer molecules entering the interstitial space and the
fraction 1-α remaining in the vascular space: 
where hiv(t) is the frequency function of transit times of the
intravascular tracer molecules, and hec(t) is the frequency function
of transit times of the extracellular tracer molecules. 
Let hin(t) be the interstitial frequency function of transit times
from capillary through interstitial space back to capillary, then
hec(t) is the convolution of hiv(t) and hin(t): 
As a first approach, the functions hiv(t) and hin(t) were parameter-
ized by monoexponential approaches (Griebel et al, 2001): 
Furthermore, assuming a monoexponential increase and thereafter
a 3-exponential decay of the arterial input function, Ca(t), the
concentration–time curve, Ct(t), in Eq. (2) can be expressed analyt-
ically. Under the assumption, that the relaxivity, β , is identical for
blood and tissue, β can be eliminated in Eq. (2) and calculations
can be performed on the base of relaxation rate changes, ∆ R(t), as
described in Eq. (1). As a consequence, tumour blood flow pt, the
extraction fraction α , and Ib and Id can be quantified by least
squares fitting from Eq. [2]. 1/Ib represents the mean transit time of
tracer molecules through the intervascular space (MTT) iv and 1/Id
represents the mean transit time of tracer molecules through the
interstitial space (MTT) in. 
The fit parameters were corrected for differences of haematocrit
in large vessels and capillaries. Haematocrit in large vessels was
measured at the end of MRI experiments and found to be 0.44 ±
0.02, while microvascular haematocrit was assumed to be 0.18
which was quantified in the same tumour model in a previous
study (Goetz, 1987). 
In vivo MR measurements of tumour blood flow 
Following approval of the local ethics committee, experiments
were performed on male Syrian golden hamsters (50–60 g body
weight) in accordance with the UKCCCR ‘Guidelines for the
welfare of animals in experimental neoplasia’ (Workman et al,
1998). For all surgical procedures, animals were anesthetized
intraperitoneally with 60 mg kg–1 body weight pentobarbital
(Nembutal, Sanofi-Leva, Hannover, Germany). Cells (5 × 106
cells) of the amelanotic hamster melanoma A-Mel-3 (Fortner et al,
1961) were implanted subcutaneously at the right flank near the
upper foreleg at the level of the heart. 3 days after implantation
when tumour had reached palpable size, a pin was implanted into
the tumour to facilitate orientation of perfusion maps obtained by
MRI and autoradiography. 5 days after implantation, when
tumours had reached a volume of 90–140 mm3, polyethylene
catheters (Portex Ltd, Hythe, Kent, England) were inserted into
the right carotid artery for arterial blood pressure measurements,
into the superior vena cava for infusion of the tracer, and into the
femoral artery for arterial blood sampling. A specially designed
animal holder for the MRI system allowed inhalation anaesthesia,
measurement of mean arterial blood pressure, and control of body
temperature. Animals were anesthetized with 1.5% isoflurane. The
temperature in the animal holder was kept constant at 28˚C. Only
animals with a stable mean arterial blood pressure between 60 and
80 mmHg during experiments were enrolled into this study in
order to exclude blood pressure mediated alterations of tumour
blood flow during experiments. 7 animals have been included in
the study. 
Autoradiographic measurements of tumour blood flow 
Immediately after MRI investigations the hamster was removed
from the MRI system for tumour perfusion autoradiography.
Tumour blood flow was quantified by the autoradiographic tissue
equilibration technique modified for the A-Mel-3 tumour as
described (Kuhnle et al, 1992). The method is based on the tissue
uptake of the inert and freely diffusible compound [4-N-methyl-
14C] iodoantipyrine (MW 314, IAP) and relies on the well-
established tracerkinetic model of Kety for freely diffusible tracers
(Kety, 1960). This tracer (Du Pont-NEN; 40 µ Ci dissolved in
0.55 ml 0.9% NaCl) was administered intravenously for 30 s while
arterial blood samples were collected every 5 s for determination
of blood concentration. Immediately after the end of infusion,
tumour tissue was rapidly resected and immediately frozen in
liquid nitrogen. The activity of 14C in arterial blood samples was
measured using a liquid scintillation counter (Rack Beta 1219,
LKB Wallac, Turku, Finland). 
Tumours were cut into serial cryosections consecutive for
tumour blood flow autoradiography (20 µ m thickness) and for
Mapping of tumour blood flow by dMRI 1657
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h(t) = (1-α )hiv (t) + α hec(t) (3)
Intravascular frequency function:          hiv(t) = Ibe− Ibt
Interstitial frequency function:              hin(t) = Ide− Idt (5)
hec(t) = hiv (t) ⊗ hin(t) (4)histology (5 µ m thickness). Tumours could be identified in
histological sections which were stained with haematoxylin and
eosin. Thus, regions of interest could be defined. Sections for
autoradiography were dried and exposed to X-ray film (NMC,
Eastman Kodak, Rochester, NY) for 2 weeks together with
calibrated  14C tissue standards (Amersham Buchler GmbH,
Braunschweig, Germany). Images of the autoradiography
showing 14C tissue distribution were acquired by a CCD-video
camera (XC-77, Sony, Cologne, Germany) which was coupled to
a macroviewer and digitized (IBAS 2.0, Kontron, Eching,
Germany). Local tumour blood flow was calculated from grey
levels according to Sakurada et al (1978) using the equation
given by Kety (1960). 
Comparison of tumour blood flow images acquired by
MRI and by autoradiography 
For correlation of perfusion data by MRI and autoradiography, the
MRI images (125 × 125 pixels) were transferred to 512 × 512
pixels with 255 grey levels by linear interpolation. 4 autoradio-
graphic specimens (20 µ m) lying in the level of the MRI map (750
µ m) were averaged to obtain a corresponding image of the spatial
heterogeneity of tumour blood flow. Perfusion maps of MRI and
autoradiography were adjusted by a specially designed image
transforming system (Kuhnle et al, 1992) (IBAS 2.0, Kontron,
Eching, Germany) to allow quantification of tumour blood flow in
corresponding areas of MRI and autoradiography images by
digital image analysis. 
Statistics 
Data are expressed as mean ± standard error of the mean. Relation
between blood flow data obtained by MRI and autoradiography
was analysed by the Spearman correlation coefficient Rs and linear
regression. A P value less than 0.05 was regarded as statistically
significant. Agreement between the 2 methods for the quantifica-
tion of tumour blood flow was evaluated and calculated in terms of
bias and precision as described by Bland and Altman (1986). 
RESULTS 
The MRI protocol used allowed dynamic T1 mapping with high
spatial resolution (in-plane resolution: 250 × 250 µ m2, slice thick-
ness: 750 µ m) with an acquisition time of 2.5 s. Maps of T1 relax-
ation times in a transaxial section of the animal at different times
before and after injection of gadopentetate dimeglumine are shown
in Figure 1. From these images, the concentration of gadopentetate
dimeglumine was calculated pixel by pixel. This single slice tech-
nique yielded a sample of approximately 2000 pixels for dynamic
investigations. 
The correlation of gadopentetate dimeglumine concentration
and T1 relaxation rate showed excellent correlation parameters
with Rs = 0.947, P < 0.001 and r2 = 0.955 (Figure 2A). The in vivo
relaxivity for gadopentetate dimeglumine in arterial blood was
5.53 mM–1 s–1. Representative concentration–time data of
gadopentetate dimeglumine in tumour and in arterial blood are
shown in Figure 2B. The multiexponential approach for the
parametrization of the arterial input function, Ca(t), provided a
1658 S Pahernik et al
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Figure 1 Representative transaxial colour-coded T1 relaxation maps of a hamster before, during and after infusion of 0.05 mmol kg–1 b.w. gadopentetate
dimeglumine (Gd-DTPA, 0.125 ml min–1 for 4 min). For MR imaging, an inversion recovery snapshot FLASH pulse sequences was applied (acquisition time: 
2.5 s, in-plane resolution: 250 × 250 µ m2, slice thickness: 750 µ m). From the Snapshot FLASH images, T1 relaxation time maps were calculated pixel by pixel.
Regions of interest (ROIs) were defined in the centre of the cavum of the left ventricle to characterize the arterial input function, and in the tumour for analysis of
tumour blood flow. A pin (p) was implanted into the tumour to facilitate orientation of tumour sections good agreement between fitted and measured data with r2 > 0.9 in
all cases. 
For identification of tumour tissue, histological section stained
with haematoxylin and eosin were performed. Tumours could be
clearly depicted compared to corresponding parameter maps
obtained by MRI and autoradiography (Figure 3). Tumour blood
flow was distributed heterogeneously revealing non-perfused
areas with values of 0 ml min–1 100 g–1 tissue and ‘hot spots’
reaching values of approximately 50 ml min–1 100 g–1 tissue.
Images of tumour blood flow from MRI and autoradiography
exhibited a similar distribution in corresponding tumour sections
(Figure 3). An example of the pixel-to-pixel correlation of
tumour blood flow between iodoantipyrine autoradiography
and dynamic contrast enhanced MRI in corresponding sections
of the A-Mel-3 tumour is shown in Figure 4A. Comparison of
maps resulted in a correlation coefficient of Rs = 0.851
(measuring grid: 600 × 600 µ m2, r = 0.775, P < 0.0001, n = 62).
Precision and bias between these 2 measurement techniques were
5.3 and 1.9 ml min–1 100 g–1 tumour tissue, respectively
(Figure 4A, B). 
Data of tumour blood flow demonstrated an enormous
heterogeneity between tumours. Global tumour blood flow of the
Mapping of tumour blood flow by dMRI 1659
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Figure 2 (A) Correlation of gadopentetate dimeglumine (Gd-DTPA) concentration measured by means of inductive coupled plasma atomic spectroscopy in
arterial blood samples (x-axis) and T1 relaxation rates determined in the cavum of the left ventricle by means of inversion recovery snapshot FLASH pulse
sequences (y-axis). Correlation parameter were as follows: Rs = 0.947, P < 0.001, r2 = 0.955, y = 5.53.x. (B) Representative concentration time curves of
gadopentetate dimeglumine in arterial blood (   ) and tumour (   ). Concentration of gadopentetate dimeglumine can be calculated from relaxation rates. For
arterial blood, regions of interest (ROIs) were defined in the cavum of the left ventricle. The concentration time data were fitted using a nonlinear algorithm 
Figure 3 Histology and corresponding colour-coded blood flow maps of an amelanotic melanoma of the Syrian golden hamster. 2 days after implantation
when tumour reached palpable size a pin (p) was implanted into the tumour to facilitate orientation of tumour sections. Tumour blood flow ranged from
nonperfused areas (0 ml min 100 g–1 tumour tissue) to ‘hot spots’ reaching values of approximately 50 ml min–1 100 g–1 tumour tissue. Iodoantipyrine
autoradiography and dynamic contrast-enhanced MRI, resulted in similar images of tumour blood flow in an individual melanoma. (A) Cryosection stained with
haematoxylin and eosin, (B) corresponding colour-coded autoradiograph of Iodo(14C) antipyrine representing the distribution of local tumour perfusion; (C)
corresponding colour-coded blood flow image calculated by dynamic contrast enhanced MRI amelanotic melanoma was 15.9 ± 1.9 ml min–1 100 g–1 tumour
tissue (range: 8.5–21.5 ml min–1 100 g–1 tumour tissue) calculated
by dynamic contrast enhanced MRI and 13.1 ± 2.0 ml min–1 100 g–1
tumour tissue (range: 7.8–21.9 ml min–1 100 g–1 tumour tissue)
calculated by iodoantipyrine autoradiography (Figure 4C). Blood
flow data of the 2 different measurement techniques revealed a
good correlation for the tumours investigated (Rs = 0.821, r = 0.72,
P = 0.014). Precision and bias between the 2 techniques were 3.8
and 2.8 ml min–1 100 g–1 tumour tissue, respectively (Figure 4D). 
In addition to tumour blood flow, the extraction fraction as well
as the parameters Ib and Id could be quantified. The mean extrac-
tion fraction, α , over all tumours investigated, was 0.15 ± 0.03. Ib
and Id were 1.72 ± 0.39 min–1 and 0.14 ± 0.02 min–1, respectively.
From these results, a mean intervascular MTT of gadopentetate
dimeglumine of 0.58 min and a mean interstitial MTT of 6.67 min
has been estimated. 
DISCUSSION 
Dynamic MR imaging combines fast MR measurement techniques
and administration of contrast agents. For analysis of uptake and
washout of contrast agents in tumours by a tracer kinetic model, a
linear relationship between contrast agent concentration and
measured MR signal has to be ascertained. Due to the complex
dependence of signal intensities upon tissue parameters, pulse
sequence parameters, and contrast agent concentration, it was
proposed to quantify gadopentetate dimeglumine concentration in
tissue using T1 relaxation times (Diesbourg et al, 1992; Tong et al,
1660 S Pahernik et al
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Figure 4 (A) Correlation of regional tumour blood flow given in corresponding pixels of 600 × 600 µ m2 of perfusion maps calculated by iodoantipyrine
autoradiography and dynamic contrast enhanced MRI (Rs = 0.851, r = 0.775, P < 0.0001, n = 62; equation of the linear regression curve: y = 0.88 x – 0.11). 
(B) Illustration of agreement with respect to regional tumour blood flow between the 2 different measurement techniques by presentation of the data as Bland
and Altman plot; precision: 5.3 ml min–1 100 g–1 tissue, bias: 1.9 ml min–1 100 g–1 tissue. (C) Relation between global tumour blood flow in 7 tumours measured
by iodoantipyrine autoradiography and dynamic contrast enhanced MRI. Global tumour blood flow of the amelanotic melanoma was 15.9 ± 1.9 ml min–1 100 g–1
tumour tissue (range: 8.5–1.5 ml min–1 100 g–1 tissue) calculated by dynamic contrast enhanced MRI and 13.1 ± 2.0 ml min 100 g–1 tissue (range: 7.8–21.9 ml
min–1 100 g–1 tissue) calculated by iodoantipyrine autoradiography. Correlation analyses for perfusion data between these 2 measurement techniques
demonstrate good correlation (Rs = 0.821, r = 0.72, P = 0.014, n = 7; equation of the linear regression curve: y = 0.88x + 0.37). (D) Illustration of agreement with
respect to global tumour blood flow between the 2 measurement techniques as Bland and Altman plot; precision: 3.8 ml min–1 100 g–1 tissue, bias: 2.8 ml min–1
100 g–1 tissue 1993; Donahue et al, 1994). For extracranial tissues, under steady-
state conditions, empirical data suggest a linear relationship
between longitudinal bulk T1 relaxation rate and tissue concentra-
tion of extracellular contrast agents (Strich et al, 1985; Burstein
et al, 1991; Donahue et al, 1994). This corresponds with the
assumption of a fast water exchange between vascular, interstitial
and cellular compartments in tissue, which mediates the compart-
mental relaxation processes. Hence, tissue relaxation is regarded
as a single bulk relaxation, which is the weighted average of the
contributions of the corresponding compartments. For dynamic
MR studies, however, an instantaneous bolus injection technique
is widely used. Hence it has to be taken into account that extra-
cellular contrast agents, such as gadolinium dimeglumine, are not
freely diffusible. Consequently, a steady state between intravas-
cular and interstitial contrast agent concentrations is probably not
reached during the first pass of the contrast agent, and thus the
assumption of a fast water exchange between vascular and
extravascular spaces may be faulty (Donahue et al, 1994; Judd
et al, 1995). In order to minimize this kind of error, we used a
prolonged bolus injection technique, as proposed by Schmiedl et al
(1991). This seems to be preferable because water exchange times
between tumour compartments remain rapid enough to validate
fast exchange due to balancing extravasation of contrast agents
into tissue (Donahue et al, 1994). 
Concentration–time data from dynamic MR imaging offers the
potential to determine microcirculatory parameters if an appro-
priate tracer kinetic model is used, which takes into account the
tracerkinetic properties of the contrast agent employed.
Gadopentetate dimeglumine (Gd-DTPA), which is widely used in
the clinical setting for contrast-enhanced MR imaging is character-
ized by a small molecular weight and its restriction to the extracel-
lular space. In the central nervous system (CNS) gadopentetate
dimeglumine behaves exactly like an intravascular tracer due to
the blood–brain barrier and is, therefore, generally suitable for
quantification of cerebral microvascular parameters by dynamic
studies. However, outside the CNS, gadopentetate dimeglumine is
rapidly extracted from the vascular into the interstitial space. The
extraction fraction estimated in different organs varies between 0.2
and 0.7 (Diesbourg et al, 1992; Tong et al, 1993; Larsson et al,
1994; Daldrup et al, 1998). In our study, we found an extraction
fraction of 0.15 ± 0.03 for the A-MEL 3 tumour tissue. 
Descriptive parameters, such as the initial uptake rate, the
maximum uptake, and the decay rate of the contrast agent in the
tumour have been introduced to determine perfusion like parame-
ters (Mayr et al, 1996; Hawighorst et al, 1998). These parameters
might be of practical use in clinical routine because they can be
simply derived from contrast agent kinetics in the tumour.
However, in addition to perfusion rate these parameters also
depend on a variety of other microcirculatory parameters such as
extraction fraction, fraction of the intravascular and extracellular
volume, as well as the arterial input function. Therefore, descrip-
tive parameters do not reflect relative or absolute perfusion rates in
the tumours (Lyng et al, 1998). 
Tissue blood flow measurements can be performed by the Kety
model when freely diffusible tracers are applied (Kety, 1960). For
contrast agents which are not freely diffusible such as gadopente-
tate dimeglumine, a modification of the Kety model has been
proposed as a first approach to the evaluation of myocardial
(Diesbourg et al, 1992; Tong et al, 1993) and tumoural (Lyng et al,
1998) uptake curves. The major drawback of these approaches is
that they do not provide blood flow values directly but rather the
product of blood flow and extraction fraction (Taylor et al, 1999).
As a consequence, the utility of the modified Kety method
depends on the a priori knowledge of the extraction fraction which
has to be determined by a separate method. Particularly in
tumours, the extraction fraction is not homogeneously distributed,
because it is governed by physiologic and morphologic properties
of tissue and varies within the tumour dependent on grading type,
vascular supply, permeability, convection and histopathologic
features such as necrotic areas (Lyng et al, 1998). Due to the
heterogeneity of tumours, the extraction fraction has thus to be
determined on a pixel-to-pixel basis. Tracer kinetic modelling
allowing simultaneous calculation of extraction fraction of
gadopentetate dimeglumine and perfusion rate is highly warranted.
A promising approach based on an extension of the Kety method
was introduced by Larson et al (1994). Unfortunately, these algo-
rithms are very sensitive to noise in the MR data and are hard to
realize under in vivo conditions in the clinical setting. 
Another approach for the estimation of microcirculatory para-
meters from dynamic MR studies relies on compartment analysis.
As a first step in this direction, simple 2-compartment models were
used (Larsson et al, 1990; Brix et al, 1991; Tofts and Kermode,
1991). However, these models did not take into account tumour
blood flow. A promising approach, which overcomes this limita-
tion and allows for the separate quantification of blood flow and
permeability-surface product, was recently proposed by Brix et al
(1999). A principal limitation of all compartment approaches is
that they consider plasma and interstitial space as compartments,
in which instantaneous mixing is assumed during the transit of
tracer molecules. Although this assumption seems to be reasonable
for the interstitial compartment, it is unlikely that it is valid for the
transit of the arterial bolus through the vascular space. Therefore,
in line with Morales and Smith (1948), a constant correction factor
was introduced by Brix et al (1999) which takes into account the
differences in the plasma concentration of the tracer between the
arterial entry and the venous exit of the capillary mesh. The perfu-
sion data, presented in this study for oro- and hypopharyngeal
carcinomas, are in good agreement with PET measurements.
However, as discussed by the authors, it is dubious to what extent
the perfusion values are overestimated by their approach. 
To overcome these problems a novel tracer kinetic approach
(Griebel et al, 1997) was applied which is based on a model origi-
nally introduced by Meier and Zierler (1963). This approach relies
on the frequency function h(t) which is the distribution of the transit
times of the tracer through the tissue after an instantaneous tracer
bolus. For extracellular tracers such as gadopentetate dimeglumine,
which are neither intravascular, nor freely diffusible, great attention
has to be directed to finding an appropriate expression for h(t). In
line with Zierler (1963) h(t) can be divided into an intravascular and
an extravasating fraction. The weighting between both fractions is
given by the extraction fraction α . This approach is universally
applicable for freely diffusible tracers (α = 1,  Kety (1960) formula)
intravascular tracers (α = 0, formula of Meier and Zierler (1963)) as
well as for intermediates (0 < α < 1, gadopentetate dimeglumine). 
In the complex in vivo investigations, performed in this study, a lot
of potential biological and experimental errors can attribute to the
variability of data, that is heterogeneity of tumour blood flow, depen-
dence of tumour blood flow upon macrohaemodynamics, changes in
the cardiovascular condition of the animals within the interval
between MRI and reference technique, difficulties in the choice of
identical ROIs within the tumour. Despite these limitations, we found
a good correlation for this tracer kinetic-based contrast-enhanced
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dation of the MRI technique showed good correlation with data
obtained by the reference method yielding good parameters for preci-
sion and bias of the technique analysed by the Bland and Altman
analysis as well as acceptable correlation parameters with r2 > 0.5 by
linear regression and Rs > 0.8 by Spearman range correlation. 
This presented MRI technique has already been transferred to a
clinical whole body 1.5 T MR scanner being a robust and practical
tool for monitoring concentration time data (de Vries et al, 2000,
2001). Application of the tracer kinetic model will allow for
quantitative mapping of tumour blood flow. Quantitative assess-
ment of tumour vascularity is of utmost relevance for the
efficacy of different treatment modalities. Moreover, the distinct
properties of tumour vascular supply are gaining more and more
attention in differential diagnosis, prognosis, therapeutic monitoring
and prediction of therapeutic success. Data from perfusion-like
semiquantitative MRI measurements indicate that tumour vascu-
larity has a prognostic impact in clinical trials and can be used to
individualize and monitor anticancer therapy (Mayr et al, 1996; de
Vries et al, 2000, 2001). These data are very promising and exciting,
and underline the potential for noninvasive quantitative measure-
ment techniques assessing precisely tumour blood flow. Knowledge
about the specific vascular microenvironment of tumours could be
used for selective antivascular cancer treatment in the future. 
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